Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

BIT/PHIL stock hub

BIT/PHIL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BIT/PHILis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

858M

Borsa Italiana

Market data

Live price

Current market quote for this ticker.

Current price

BIT/PHIL

In the news

Latest news · BIT/PHIL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 13P50 15.3P75 18.4

Trailing P/E3.7

P25 14.4P50 21.2P75 24.6

ROE89.6

P25 3.1P50 8.5P75 13.3

ROIC4,072.6

P25 5.3P50 8.5P75 15.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BIT/PHIL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

210

Groups with data

Currency

EUR

Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Italy
Country code	IT
Employees	214
Employees Change	31%
Employees Change Percent	16.94
Enterprise value	EUR 489.7M
Exchange	Borsa Italiana
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	IT0005373789
Last refreshed	2026-05-10
Market cap	EUR 858M
Price	EUR 21.3
Price currency	EUR
Rev Per Employee	1,494,065.42x
Sector	Healthcare
Sic	2836
Symbol	bit/PHIL
Website	https://www.philogen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	26.77%
EV Earnings	2.13x
EV/EBIT	1.91x
EV/EBITDA	1.87x
EV/FCF	1.85x
EV/Sales	1.53x
FCF yield	30.84%
P/B ratio	2.29x
P/E ratio	3.74x
P/S ratio	2.68x
PE Ratio3 Y	27.48x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	80.36%
EBITDA Margin	81.35%
FCF margin	82.75%
Gross margin	87.62%
Gross Profit	EUR 280.2M
Gross Profit Growth	366.77%
Gross Profit Growth Q	338.24%
Gross Profit Growth5 Y	81.63%
Net Income	EUR 229.7M
Net Income Growth	407.1%
Net Income Growth Q	302.2%
Net Income Growth Years	2%
Net Income Growth5 Y	273.5%
Pretax Margin	81.35%
Profit Margin	71.83%
Profit Per Employee	EUR 1.1M
Profitable Years	2
ROA	53.02
Roa5y	10.96
ROCE	66.56
ROE	89.63
Roe5y	19.55
ROIC	4,072.6
Roic5y	210.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-2.3%
Cagr3y	12.4%
Cagr5y	7.76%
EPS Growth	408.9
EPS Growth Q	300.1
EPS Growth Years	2
EPS Growth5 Y	273.9
FCF Growth	584.09%
FCF Growth Q	453.64%
OCF Growth	556.1%
OCF Growth Q	448.95%
Revenue Growth	313.82x
Revenue Growth Q	310.85x
Revenue Growth Years	2x
Revenue Growth3 Y	333.71x
Revenue Growth5 Y	61.36x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.06
Assets	EUR 437.3M
Cash	EUR 379.2M
Current Assets	EUR 397.9M
Current Liabilities	EUR 51.3M
Debt	EUR 10.9M
Debt EBITDA	EUR 0.04
Debt Equity	EUR 0.03
Debt FCF	EUR 0.04
Equity	EUR 373.9M
Interest Coverage	776.3
Liabilities	EUR 63.5M
Long Term Assets	EUR 39.5M
Long Term Liabilities	EUR 12.2M
Net Cash	EUR 368.3M
Net Cash By Market Cap	EUR 42.93
Net Cash Growth	260.42%
Net Debt EBITDA	EUR -1.42
Net Debt Equity	EUR -0.99
Net Debt FCF	EUR -1.39
Tangible Book Value	EUR 372.8M
Tangible Book Value Per Share	EUR 9.25
WACC	4.14

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.76
Inventory Turnover	12.72
Net Working Capital	EUR -31.4M
Quick ratio	7.69
Working Capital	EUR 346.6M
Working Capital Turnover	EUR 1.38

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.05%
Dividend per share	EUR 0.7
Dividend Yield	3.29%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-2.29%
200-day SMA	22.53
3Y total return	42%
50-day SMA	21.62
50-day SMA vs 200-day SMA	50under200
5Y total return	45.29%
All Time High	27.8
All Time High Change	-23.38%
All Time High Date	2025-06-11
All Time Low	12.6
All Time Low Change	69.05%
All Time Low Date	2021-07-20
ATR	0.63
Beta	-0.02
Beta1y	-0.61
Beta2y	-0.33
Ch YTD	-8.58
High	21.55
High52	27.8
High52 Date	2025-06-11
High52ch	-23.38%
Low	21.25
Low52	19.56
Low52 Date	2026-04-09
Low52ch	8.9%
Ma50ch	-1.47%
Price vs 200-day SMA	-5.45%
RSI	48.51
RSI Monthly	51.73
RSI Weekly	46.39
Sharpe ratio	-0.01x
Sortino ratio	0.16
Total Return	3.33%
Tr YTD	-8.58
Tr1m	0.24%
Tr1w	-3.18%
Tr3m	0.47%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 256.9M
Operating Income Growth	560.4
Operating Income Growth Q	400.3
Operating margin	80.36

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	10,746,175%
Net Borrowing	-1,152,000
Shares Institutions	3.11%
Shares Out	40,281,214
Shares Qo Q	1.02%
Shares Yo Y	-0.05%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 258.5M
Average Volume	18,184.8x
Bv Per Share	9.28
CAPEX	EUR -3.4M
Ch1m	0.24
Ch1w	-3.18
Ch1y	-2.29
Ch3m	0.47
Ch3y	42
Ch5y	45.29
Ch6m	-10.5
Change	-1.84%
Change From Open	-1.16
Close	21.7
Days Gap	-0.69
Depreciation Amortization	3,144,000
Dollar Volume	288,742.8
Earnings Date	2026-05-12
EBIT	EUR 256.9M
EBITDA	EUR 260.1M
EPS	EUR 5.7
F Score	7
FCF	EUR 264.6M
FCF EV Yield	54.03x
FCF Per Share	EUR 6.57
Financing CF	-2,989,000
Fiscal Year End	December
Founded	1,996
Graham Number	34.50111
Graham Upside	61.98
Income Tax	EUR 30.4M
Investing CF	-168,348,000
Is Primary Listing	1
Last Earnings Date	2026-03-27
Last Report Date	2025-12-31
Lynch Fair Value	EUR 143
Lynch Upside	569
Ma150	22.45
Ma150ch	-5.12%
Ma20	21.09
Ma20ch	1.02%
Net CF	96,626,000
Next Earnings Date	2026-05-12
Open	21.55
P FCF Ratio	3.24
P OCF Ratio	3.2
Position In Range	16.67
Ppne	24,849,000
Price Date	2026-05-08
Price EBITDA	EUR 3.3
Ptbv Ratio	2.3
Relative Volume	0.76x
Revenue	319,730,000x
SBC By Revenue	1.9x
Share Based Comp	6,081,000
Tax By Revenue	9.52x
Tax Rate	11.7%
Tr6m	-10.5%
Volume	13,556
Z Score	12.79

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BIT/PHIL dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.3%

$0.70 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

Annualized growth of the per-share dividend

Total shareholder yield

+3.3%

Dividend yield + buyback yield combined

Performance

BIT/PHIL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BIT/PHIL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.1%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

BIT/PHIL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.5

Neutral momentum band

Price vs 200-day MA

-5.4%

50/200-day relationship not available

Beta (5Y)

-0.02

Less volatile than the market

Sharpe ratio

-0.01

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BIT/PHIL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bit/PHIL stock rating?

bit/PHIL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bit/PHIL analysis?

The full report lives at /stocks/bit/PHIL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bit/PHIL?

The latest report frames bit/PHIL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bit/PHIL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.